Michela Cerno
Overview
Explore the profile of Michela Cerno including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
161
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Damiani D, Tiribelli M, Geromin A, Cerno M, Sperotto A, Toffoletti E, et al.
Ann Hematol
. 2012 Aug;
91(12):1937-43.
PMID: 22893485
We retrospectively analysed 78 patients with relapsed (n = 38), primary refractory (n = 34) or untreated (n = 6) acute myeloid leukaemia (AML) who underwent allogeneic HSCT at our...
12.
Zaja F, Geromin A, Patriarca F, Puglisi S, Cerno M, Sperotto A, et al.
Am J Hematol
. 2011 Aug;
86(9):790-2.
PMID: 21830231
No abstract available.
13.
Sperotto A, Damiani D, Zaja F, Patriarca F, Geromin A, Cerno M, et al.
Adv Clin Path
. 2009 Sep;
6(2):77-85.
PMID: 19753729
Autologous stem cell transplantation (ASCT) is largely employed in primary resistant or recurrent Hodgkin's Lymphoma (HL), while its role early in the course of the disease is still controversial. Our...
14.
Damiani D, Grimaz S, Sperotto A, Geromin A, Skert C, Cerno M, et al.
Adv Clin Path
. 2007 Jun;
6(1):11-6.
PMID: 17582943
Regardless the mobilization procedure used there is a great variability from patient to patient in the yield of CD34 collections for autologous transplantation. We analyzed retrospectively our non-Hodgkin's lymphoma survey...
15.
Patriarca F, Skert C, Bonifazi F, Sperotto A, Fili C, Stanzani M, et al.
Haematologica
. 2006 Sep;
91(9):1268-72.
PMID: 16956831
We evaluated the incidence, risk factors, and clinical outcome of late-onset non-infectious pulmonary complications (LONIPC) in 599 patients who underwent hematopoietic allogeneic stem cell transplantation (HSCT). The 2-year cumulative incidence...
16.
Patriarca F, Skert C, Sperotto A, Zaja F, Falleti E, Mestroni R, et al.
Exp Hematol
. 2006 Mar;
34(3):389-96.
PMID: 16543073
Objective: Chronic graft-vs-host disease (GVHD) has certain similarities with autoimmune diseases and is associated with the development of various autoantibodies in some patients. In this study, we analyzed the occurrence...
17.
Skert C, Patriarca F, Sperotto A, Cerno M, Fili C, Zaja F, et al.
Haematologica
. 2006 Feb;
91(2):258-61.
PMID: 16461315
Scleroderma may be one of the most severe forms of chronic graft-versus-host disease (GVHD). We retrospectively evaluated its incidence, predictor variables and outcome in 133 patients who survived at least...